- Home
- HIT vs PRE Comparison
HIT vs PRE Comparison
Compare HIT & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HIT | PRE |
|---|---|---|
| Founded | 1964 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 152.4M | 131.3M |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | HIT | PRE |
|---|---|---|
| Price | $1.07 | $15.16 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | $2.50 | ★ $32.00 |
| AVG Volume (30 Days) | ★ 506.5K | 130.7K |
| Earning Date | 11-10-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | $30,723,490.00 | ★ $77,079,000.00 |
| Revenue This Year | $70.02 | $219.28 |
| Revenue Next Year | $44.08 | $124.38 |
| P/E Ratio | $50.12 | ★ N/A |
| Revenue Growth | 55.15 | ★ 201.54 |
| 52 Week Low | $0.51 | $3.10 |
| 52 Week High | $7.59 | $17.99 |
Technical Indicators
Market Signals| Indicator | HIT | PRE |
|---|---|---|
| Relative Strength Index (RSI) | 29.25 | 60.19 |
| Support Level | $1.04 | $12.93 |
| Resistance Level | $1.16 | $14.50 |
| Average True Range (ATR) | 0.16 | 1.12 |
| MACD | 0.02 | 0.11 |
| Stochastic Oscillator | 2.86 | 93.19 |
Price Performance
Historical ComparisonAbout HIT Health In Tech Inc. Class A Common Stock
Health In Tech Inc is an insurance technology platform company. It offers a marketplace that processes in the healthcare industry through vertical integration, process simplification, and automation. The group removed friction and complexities, it streamlined the underwriting, sales, and service process for insurance companies, licensed brokers, and TPAs.
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.